Are cerebrovascular factors involved in Alzheimer's disease?

被引:64
|
作者
Kudo, T
Imaizumi, K
Tanimukai, H
Katayama, T
Sato, N
Nakamura, Y
Tanaka, T
Kashiwagi, Y
Jinno, Y
Tohyama, M
Takeda, M
机构
[1] Osaka Univ, Grad Sch Med, Dept Clin Neurosci Psychiat, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan
[3] Tanabe Seiyaku Co Ltd, Yodogawa Ku, Osaka 5320031, Japan
关键词
Alzheimer's disease; cerebrovascular disorder; vascular dementia; risk factor; presenilin;
D O I
10.1016/S0197-4580(00)00129-9
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Recent epidemiological studies have shown that vascular risk factors may be involved in Alzheimer's disease (AD) as well as dementia in general. To investigate the relation between a vascular disorder and AD pathology, current criteria are defective because most depend on exclusion of a cerebrovascular disorder. Epidemiological studies have indicated the possibilities that arteriosclerosis, abnormal blood pressure, diabetes mellitus and smoking may be related to the pathogenesis of AD. As for the mechanism that vascular disorders influence AD, it is presumed that amyloid deposition may be caused by a vascular disorder. Alternatively, a vascular event may cause progression of subclinical AD to a clinical stage. Insulin resistance and apolipoprotein E may also be involved in these mechanisms. Our studies show that ischemia-induced the Alzheimer-associated gene presenilin 1 (PS1) and endoplasmic reticulum-stress, generated from a vascular disorder, may unmask clinical AD symptoms caused by presenilin mutation, suggesting that a vascular factor might be involved in the onset of familial AD. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 50 条
  • [1] Cerebrovascular risk factors in Alzheimer's disease:: Brain hemodynamics and pharmacogenomic implications
    Cacabelos, R
    Fernández-Novoa, L
    Lombardi, V
    Corzo, L
    Pichel, V
    Kubota, Y
    NEUROLOGICAL RESEARCH, 2003, 25 (06) : 567 - 580
  • [2] Mixed dementia: Alzheimer's and cerebrovascular disease
    Rockwood, K
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 39 - 46
  • [3] Cerebrovascular disease in ageing and Alzheimer's disease
    Love, Seth
    Miners, J. Scott
    ACTA NEUROPATHOLOGICA, 2016, 131 (05) : 645 - 658
  • [4] Cerebrovascular disease in ageing and Alzheimer’s disease
    Seth Love
    J. Scott Miners
    Acta Neuropathologica, 2016, 131 : 645 - 658
  • [5] Cerebrovascular lesions in Alzheimer's disease
    Sharma, J. C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (02) : 182 - 183
  • [6] Are vascular factors involved in Alzheimer's disease? Facts and theories
    Di Iorio, A
    Zito, M
    Lupinetti, M
    Abate, G
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 11 (06) : 345 - 352
  • [7] Are vascular factors involved in Alzheimer’s disease? Facts and theories
    A. Di Iorio
    M. Zito
    M. Lupinetti
    G. Abate
    Aging Clinical and Experimental Research, 1999, 11 : 345 - 352
  • [8] Physiological separation of Alzheimer's disease and Alzheimer's disease with significant levels of cerebrovascular symptomology and healthy controls
    Lithgow, Brian J.
    Dastgheib, Zeinab
    Anssari, Neda
    Mansouri, Behzad
    Blakley, Brian
    Ashiri, Mehrangiz
    Moussavi, Zahra
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 2021, 59 (7-8) : 1597 - 1610
  • [9] Physiological separation of Alzheimer’s disease and Alzheimer’s disease with significant levels of cerebrovascular symptomology and healthy controls
    Brian J. Lithgow
    Zeinab Dastgheib
    Neda Anssari
    Behzad Mansouri
    Brian Blakley
    Mehrangiz Ashiri
    Zahra Moussavi
    Medical & Biological Engineering & Computing, 2021, 59 : 1597 - 1610
  • [10] Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia
    Migrino, Raymond Q.
    Karamanova, Nina
    Truran, Seth
    Serrano, Geidy E.
    Davies, Hannah A.
    Madine, Jillian
    Beach, Thomas G.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)